BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 17108985)

  • 1. Production of isoprenoid pharmaceuticals by engineered microbes.
    Chang MC; Keasling JD
    Nat Chem Biol; 2006 Dec; 2(12):674-81. PubMed ID: 17108985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic engineering of microorganisms for isoprenoid production.
    Kirby J; Keasling JD
    Nat Prod Rep; 2008 Aug; 25(4):656-61. PubMed ID: 18663389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids.
    Martin VJ; Pitera DJ; Withers ST; Newman JD; Keasling JD
    Nat Biotechnol; 2003 Jul; 21(7):796-802. PubMed ID: 12778056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced biofuel production in microbes.
    Peralta-Yahya PP; Keasling JD
    Biotechnol J; 2010 Feb; 5(2):147-62. PubMed ID: 20084640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reevaluating synthesis by biology.
    Yadav VG; Stephanopoulos G
    Curr Opin Microbiol; 2010 Jun; 13(3):371-6. PubMed ID: 20447859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives and limits of engineering the isoprenoid metabolism in heterologous hosts.
    Muntendam R; Melillo E; Ryden A; Kayser O
    Appl Microbiol Biotechnol; 2009 Oct; 84(6):1003-19. PubMed ID: 19669755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-level production of amorpha-4,11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli.
    Newman JD; Marshall J; Chang M; Nowroozi F; Paradise E; Pitera D; Newman KL; Keasling JD
    Biotechnol Bioeng; 2006 Nov; 95(4):684-91. PubMed ID: 16878333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manufacturing molecules through metabolic engineering.
    Keasling JD
    Science; 2010 Dec; 330(6009):1355-8. PubMed ID: 21127247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying and engineering the ideal microbial terpenoid production host.
    Moser S; Pichler H
    Appl Microbiol Biotechnol; 2019 Jul; 103(14):5501-5516. PubMed ID: 31129740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s.
    Chang MC; Eachus RA; Trieu W; Ro DK; Keasling JD
    Nat Chem Biol; 2007 May; 3(5):274-7. PubMed ID: 17438551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terpenoids: opportunities for biosynthesis of natural product drugs using engineered microorganisms.
    Ajikumar PK; Tyo K; Carlsen S; Mucha O; Phon TH; Stephanopoulos G
    Mol Pharm; 2008; 5(2):167-90. PubMed ID: 18355030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current prospects for the production of coenzyme Q10 in microbes.
    Cluis CP; Burja AM; Martin VJ
    Trends Biotechnol; 2007 Nov; 25(11):514-21. PubMed ID: 17935805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of systems biology in engineering microbes for biofuel production.
    Mukhopadhyay A; Redding AM; Rutherford BJ; Keasling JD
    Curr Opin Biotechnol; 2008 Jun; 19(3):228-34. PubMed ID: 18515068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational analysis of phenotypic space in heterologous polyketide biosynthesis--applications to Escherichia coli, Bacillus subtilis, and Saccharomyces cerevisiae.
    Boghigian BA; Lee K; Pfeifer BA
    J Theor Biol; 2010 Jan; 262(2):197-207. PubMed ID: 19833139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioprocess engineering for microbial synthesis and conversion of isoprenoids.
    Schewe H; Mirata MA; Schrader J
    Adv Biochem Eng Biotechnol; 2015; 148():251-86. PubMed ID: 25893480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities for yeast metabolic engineering: Lessons from synthetic biology.
    Krivoruchko A; Siewers V; Nielsen J
    Biotechnol J; 2011 Mar; 6(3):262-76. PubMed ID: 21328545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enabling technologies to advance microbial isoprenoid production.
    Chen Y; Zhou YJ; Siewers V; Nielsen J
    Adv Biochem Eng Biotechnol; 2015; 148():143-60. PubMed ID: 25549781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic engineering and synthetic biology for isoprenoid production in Escherichia coli and Saccharomyces cerevisiae.
    Navale GR; Dharne MS; Shinde SS
    Appl Microbiol Biotechnol; 2021 Jan; 105(2):457-475. PubMed ID: 33394155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialic acid and N-acyl sialic acid analog production by fermentation of metabolically and genetically engineered Escherichia coli.
    Lundgren BR; Boddy CN
    Org Biomol Chem; 2007 Jun; 5(12):1903-9. PubMed ID: 17551639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering Microbes to Synthesize Plant Isoprenoids.
    Zhou K; Edgar S; Stephanopoulos G
    Methods Enzymol; 2016; 575():225-45. PubMed ID: 27417931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.